AU2002252981A1 - Pharmaceutical compositions containing beta-mimetic agents and having few side-effects - Google Patents

Pharmaceutical compositions containing beta-mimetic agents and having few side-effects

Info

Publication number: AU2002252981A1
Authority: AU; Australia
Prior art keywords: effects; pharmaceutical compositions; compositions containing; few side; containing beta
Prior art date: 2001-02-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002252981A

Inventor

Karl-Heinz Bozung

Michel Pairet

Richard Reichl

Alexander Walland

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Boehringer Ingelheim Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-01

Filing date

2002-01-24

Publication date

2002-08-12

2002-01-24 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2002-08-12 Publication of AU2002252981A1 publication Critical patent/AU2002252981A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2002252981A 2001-02-01 2002-01-24 Pharmaceutical compositions containing beta-mimetic agents and having few side-effects Abandoned AU2002252981A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10104370.8		2001-02-01
DE10104370A DE10104370A1 (en)	2001-02-01	2001-02-01	Medicinal compositions with fewer side effects
PCT/EP2002/000704 WO2002060533A2 (en)	2001-02-01	2002-01-24	Pharmaceutical compositions containing beta-mimetic agents and having few side-effects

Publications (1)

Publication Number	Publication Date
AU2002252981A1 true AU2002252981A1 (en)	2002-08-12

Family

ID=7672383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002252981A Abandoned AU2002252981A1 (en)	2001-02-01	2002-01-24	Pharmaceutical compositions containing beta-mimetic agents and having few side-effects

Country Status (5)

Country	Link
EP (1)	EP1357976A2 (en)
AU (1)	AU2002252981A1 (en)
CA (1)	CA2436510A1 (en)
DE (1)	DE10104370A1 (en)
WO (1)	WO2002060533A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7214687B2 (en)	1999-07-14	2007-05-08	Almirall Ag	Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
EP1924553A1 (en)	2005-08-08	2008-05-28	Argenta Discovery Limited	Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
GB0516313D0 (en)	2005-08-08	2005-09-14	Argenta Discovery Ltd	Azole derivatives and their uses
ES2298049B1 (en)	2006-07-21	2009-10-20	Laboratorios Almirall S.A.	PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO.
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DE19827178A1 (en) *	1998-06-18	2000-04-27	Boehringer Ingelheim Pharma	Stable aerosol formulations containing two or more bioactives used for pharmaceuticals

2001
- 2001-02-01 DE DE10104370A patent/DE10104370A1/en not_active Withdrawn
2002
- 2002-01-24 WO PCT/EP2002/000704 patent/WO2002060533A2/en not_active Ceased
- 2002-01-24 CA CA002436510A patent/CA2436510A1/en not_active Abandoned
- 2002-01-24 AU AU2002252981A patent/AU2002252981A1/en not_active Abandoned
- 2002-01-24 EP EP02722033A patent/EP1357976A2/en not_active Ceased

Also Published As

Publication number	Publication date
DE10104370A1 (en)	2002-08-08
CA2436510A1 (en)	2002-08-08
WO2002060533A2 (en)	2002-08-08
EP1357976A2 (en)	2003-11-05
WO2002060533A3 (en)	2002-12-12

Similar Documents

Publication	Publication Date	Title
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2002306269A1 (en)	2003-05-15	N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
IL161616A0 (en)	2004-09-27	Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
IL158044A0 (en)	2004-03-28	Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en)	2004-05-12	Bisarylimidazol derivatives and pharmaceutical compositions containing the same
AU2002341205A1 (en)	2002-11-18	Pharmaceutical compositions comprising cyclosporin
IL156812A0 (en)	2004-02-08	Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
AU2002302147A1 (en)	2003-06-12	Pharmaceutical composition
AU2002258221A1 (en)	2003-05-08	Medicinal composition
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
IL159006A0 (en)	2004-05-12	Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same
AU2002252981A1 (en)	2002-08-12	Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
AU2002254455A1 (en)	2002-10-15	Taxoid anti-tumor agents and pharmaceutical compositions thereof
AU2002246659A1 (en)	2002-08-06	Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU4543500A (en)	2000-10-23	Pharmaceutical compositions and uses
AU2002246658A1 (en)	2002-07-24	Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001262928A1 (en)	2001-12-17	Pharmaceutical compositions and their use
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU3586401A (en)	2001-09-17	Pharmaceutical composition
AU2001259564A1 (en)	2002-01-21	Pharmaceutical compositions and methods for use
AU2001278705A1 (en)	2002-02-25	Pharmaceutical composition
AUPR529701A0 (en)	2001-06-21	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2004-02-12	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase